George Collins is vice president, Vanderbilt Chemicals LLC.
Mitigating the Risk from Excipient Variability
This article reviews sources of excipient variability, including raw materials and processing, both of which may vary from supplier to supplier and from plant to plant for a single manufacturer.
Understanding Concomitant Components in Pharmaceutical Excipients
Viewpoint: Continued dialogue among pharma stakeholders is needed to achieve consensus regarding excipient composition.
Additives and Processing Aids in Pharmaceutical Excipients
This article seeks to encourage continued dialogue among stakeholders to achieve consensus regarding excipient additives and processing aids.
The Real Complexity of Excipient Composition
This article seeks to promote dialogue among stakeholders to facilitate consensus regarding requirements for excipients.